Ranbaxy subsidiary bags US FDA nod to market hypertension drug
Ranbaxy Laboratories wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc. (RPI) has obtained tentative approval from the US Foods and Drug Administration (USFDA) for marketing of Lisinopril +